Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|December 13, 2005
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trialBradi B Granger, Karl Swedberg, Inger Ekman, et al.
The American Journal of Cardiology|January 27, 2009
Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphologyZeeshan Syed, Benjamin M Scirica, Satishkumar Mohanavelu, et al.
Journal of the American College of Cardiology|February 1, 1988
Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarctionC D de Langen, R F Hanich, E L Michelson, et al.
Heart Disease (Hagerstown, Md.)|November 27, 2001
Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study GroupA H Gradman, A Lewin, B T Bowling, et al.
The American Journal of Cardiology|March 16, 2001
Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study InvestigatorsR A Kloner, M Weinberger, J L Pool, et al.
The American Journal of Cardiology|June 5, 1989
Dilevalol compared with propranolol and placebo for systemic hypertensionJ A Schoenberger, W H Frishman, J D Wallin, et al.
The American Journal of Cardiology|February 5, 2003
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectorisCarl J Pepine, Rhonda M Cooper-DeHoff, Robert J Weiss, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programmeMarc A Pfeffer, Karl Swedberg, Christopher B Granger, et al.
European Heart Journal|November 13, 2008
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failurePutte Abrahamsson, Joanna Dobson, Christopher B Granger, et al.
European Heart Journal|November 7, 2008
Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programmeAlain Cohen-Solal, John J V McMurray, Karl Swedberg, et al.
Pageof 19